{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:41:40Z","timestamp":1792676500444,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neurol.2026.03.005","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:30:05Z","timestamp":1775129405000},"page":"352-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Brain atrophy in multiple sclerosis: Mechanisms, measurement, and clinical translation"],"prefix":"10.1016","volume":"182","author":[{"given":"I.","family":"Koubiyr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Schoonheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurol.2026.03.005_bib0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13317-019-0117-5","article-title":"Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options","volume":"10","author":"Andravizou","year":"2019","journal-title":"Autoimmun highlights"},{"key":"10.1016\/j.neurol.2026.03.005_bib0110","doi-asserted-by":"crossref","unstructured":"Sastre-Garriga J, Pareto D, Battaglini M, Rocca MA, Ciccarelli O, Enzinger C, et al. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nature reviews. Neurology, 16(3)<\/I>:171-182. DOI. 10.1038\/s41582-020-0314-x.","DOI":"10.1038\/s41582-020-0314-x"},{"issue":"11","key":"10.1016\/j.neurol.2026.03.005_bib0115","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/14737175.2024.2398484","article-title":"Brain atrophy assessment in multiple sclerosis: technical- and subject-related barriers for translation to real-world application in individual subjects","volume":"24","author":"Zivadinov","year":"2024","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"10.1016\/j.neurol.2026.03.005_bib0120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.neurol.2026.03.005_bib0125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"10.1016\/j.neurol.2026.03.005_bib0130","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/awv398","article-title":"The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain","volume":"139","author":"Haider","year":"2016","journal-title":"Brain"},{"issue":"Pt 11","key":"10.1016\/j.neurol.2026.03.005_bib0135","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurol.2026.03.005_bib0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/WNL.0b013e31820a0cc4","article-title":"Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI","volume":"76","author":"Geurts","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2026.03.005_bib0145","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1212\/WNL.0b013e31827b910b","article-title":"The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects","volume":"80","author":"Minagar","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2026.03.005_bib0150","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241306684","article-title":"Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance","volume":"17","author":"Dal-Bianco","year":"2024","journal-title":"Ther Adv Neurol Disord"},{"issue":"23","key":"10.1016\/j.neurol.2026.03.005_bib0155","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/WNL.0b013e3181e24136","article-title":"Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes","volume":"74","author":"De Stefano","year":"2010","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2026.03.005_bib0160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1212\/WNL.0000000000003542","article-title":"Brain MRI atrophy quantification in MS: from methods to clinical application","volume":"88","author":"Rocca","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2026.03.005_bib0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00401-025-02893-4","volume":"149","author":"Rodriguez-Mogeda","year":"2025","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.neurol.2026.03.005_bib0170","doi-asserted-by":"crossref","first-page":"e200222","DOI":"10.1212\/NXI.0000000000200222","article-title":"Vulnerability of thalamic nuclei at CSF interface during the entire course of multiple sclerosis","volume":"11","author":"Koubiyr","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"10.1016\/j.neurol.2026.03.005_bib0175","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41582-024-01006-1","article-title":"Assessing disease progression and treatment response in progressive multiple sclerosis","volume":"20","author":"Comi","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2026.03.005_bib0180","doi-asserted-by":"crossref","first-page":"e209444","DOI":"10.1212\/WNL.0000000000209444","article-title":"Using the progression independent of relapse activity framework to unveil the pathobiological foundations of multiple sclerosis","volume":"103","author":"Ciccarelli","year":"2024","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2026.03.005_bib0185","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.25145","article-title":"Deep gray matter volume loss drives disability worsening in multiple sclerosis","volume":"83","author":"Eshaghi","year":"2018","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2026.03.005_bib0190","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2026.03.005_bib0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/acn3.52261","article-title":"Cortical lesions impact cognitive decline in multiple sclerosis via volume loss of non-lesional cortex","volume":"12","author":"Krijnen","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2026.03.005_bib0200","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp-2023-332332","volume":"95","author":"Alba-Arbalat","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378726004972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378726004972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:14:15Z","timestamp":1792674855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378726004972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0035378726004972"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2026.03.005","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain atrophy in multiple sclerosis: Mechanisms, measurement, and clinical translation","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2026.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}